The expression of Wnt3a, Fzd3, TCF4, and cyclin D significantly declined after MSCT, compared with the IBD group without MSCT, whereas expression of GSK-3β was upregulated to normal levels and was higher than in IBD rat models. The gene discussed is TCF4; the disease is inflammatory bowel disease.